Oxazer-100 Injection

Regulated Product — Business License Required

B2B and export product information for licensed and authorized business customers. Contact our team regarding bulk supply, documentation, and applicable commercial, import, and export requirements. This page is not a storefront and no purchasing, checkout, or pricing is offered here.

Product photography not yet supplied — this space will show official packaging imagery once provided by the business.

Product Overview

Oxazer-100 Injection contains oxaliplatin, a platinum-based cytotoxic (chemotherapy) medicine. Its labelling describes it for the treatment of cancer of the colon and rectum, among other cancers. It is described as damaging the DNA and RNA of cancer cells to stop or slow their growth and multiplication. The dose, duration, and interval are set by the doctor according to the stage and progress of the disease; it is given only by a professional doctor into the veins, and the benefits can take weeks or months to be felt.

Active ingredient
Oxaliplatin
Strength
100 mg
Dosage form
Concentrate / powder for solution for infusion
Therapeutic class
Platinum-based alkylating agent (antineoplastic)
Regulatory status
Prescription / regulated — confirmed per enquiry and destination market
Availability
Confirmed per enquiry

Product Information

The following description reflects information associated with this product’s labelling. It has not been independently clinically verified by SDO Pharma and is provided for business and product-identification purposes only. It is not medical advice and does not replace the manufacturer’s official prescribing information.

Described Uses

  • Described for the treatment of cancer of the colon and rectum
  • Also listed for ovarian cancer, small cell lung cancer, cervical cancer, testicular cancer, and lung cancer
  • Described as damaging the DNA and RNA of cancer cells to stop their growth and multiplication
Note: SDO Pharma has not independently verified the manufacturer’s efficacy claims for this product and makes no additional medical or clinical claims beyond what is described here. We do not claim FDA, UAE, EU, or other specific regulatory approval for this product unless independently verified. This is a prescription / regulated-status product; patient dispensing is the responsibility of the licensed business customer, not SDO Pharma.

Described Dosage & Administration

  • Given only by a professional doctor, into the veins
  • The dose, duration, and interval are determined by the doctor according to the disease stage and progress
  • It should not be taken incorrectly or in excess, as this can cause serious side effects
  • Benefits can take weeks or months; it should not be stopped unless the doctor advises

Described Side Effects

Commonly described side effects include:

  • Abdominal pain
  • Injection site reaction
  • Weight gain
  • Hair loss
  • Constipation
  • Skin disorder
  • Decreased appetite and taste change
  • Swelling and allergic reaction
  • Fatigue
  • Nausea, vomiting, and diarrhoea
  • Low blood platelets
  • Headache

These are described as commonly temporary. The doctor should be consulted immediately if vomiting or another effect persists.

Precautions

  • The doctor should be informed of heart disease, any medicines being taken for infections, or liver or kidney issues
  • Described as strictly not recommended during pregnancy or breastfeeding
  • Driving should be avoided as the medicine causes dizziness

This summary is provided for informational purposes only and does not replace the manufacturer’s official product labelling or professional medical advice.

B2B, Import & Export

B2B, Import & Export Enquiries

SDO Pharma supports business enquiries for pharmaceutical and healthcare products, including bulk and export supply, subject to applicable licensing, regulatory, import, and export requirements. Requirements vary according to the destination market and the nature of the transaction.

We do not claim that this product is available for import into every country, and we do not claim FDA, UAE, EU, or other specific regulatory approval unless independently verified. Applicable documentation — including a valid Drug License, tax registration, and Importer Exporter Code (IEC) where relevant — is discussed directly with our team as part of the enquiry process. This is a regulated / prescription-status product supplied only to licensed and authorized business customers; SDO Pharma does not sell it directly to individual patients or consumers. See our Regulated Products Policy.

Product Enquiry

Request Product Information

Interested in this product for your business? Submit your enquiry and our team will contact you regarding bulk supply, documentation, and applicable requirements.

Frequently Asked Questions

Per its labelling it contains oxaliplatin and is used for the treatment of cancer of the colon and rectum, among other cancers. SDO Pharma has not independently verified the manufacturer’s claims and does not claim any specific regulatory approval unless independently confirmed.

Its labelling describes it as given only by a professional doctor into the veins, with the dose, duration, and interval set by the doctor according to the disease stage and progress.

Licensed and authorized business customers can submit the product enquiry form above or contact our team directly. Product availability, documentation, and supply arrangements are confirmed per enquiry.

Availability depends on the destination market’s regulatory requirements and cannot be confirmed without a direct enquiry. See our B2B, Import & Export Enquiries section above.

Explore More

Related Product Categories

SDO Pharma works across several pharmaceutical and healthcare product categories for business customers.

View Products & Services